Skip to main content

HCC 23: Prostate, Breast, and Other Cancers and Tumors

HCC 23, Prostate, Breast, and Other Cancers and Tumors, is one of the 115 payment categories in the CMS-HCC V28 model. 234 ICD-10-CM codes map to it in the payment year 2027 mapping, and a documented diagnosis in the category adds a relative factor of 0.186 to the risk score of a community, non-dual, aged beneficiary (0.233 disabled, 0.197 institutional). It is overridden when a more severe category in its hierarchy is present (HCC 17, HCC 18, HCC 19, HCC 20, HCC 21, HCC 22).

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: ICD-10-CM to HCC mapping PY2027 initial (effective dates of service 2026, payment year 2027); CMS-HCC V28 model software V2826.115.T2 (effective payment year 2027). Next CMS release: PY2027 midyear final mapping (spring 2027) and PY2028 proposed model (February 2027).
Mapped ICD-10-CM codes
234
Factor, community non-dual aged
0.186
Factor, institutional
0.197
Hierarchy
Overridden by HCC 17, HCC 18, HCC 19, HCC 20, HCC 21, HCC 22

Relative factors by segment

Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.

CMS-HCC V28 relative factors for HCC 23 by model segment
SegmentModel codeRelative factor
Community, non-dual, agedCNA_HCC230.186
Community, non-dual, disabledCND_HCC230.233
Community, full-benefit dual, agedCFA_HCC230.196
Community, full-benefit dual, disabledCFD_HCC230.218
Community, partial-benefit dual, agedCPA_HCC230.203
Community, partial-benefit dual, disabledCPD_HCC230.237
Long-term institutionalINS_HCC230.197

Hierarchy

Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) or HCC 20 (Lung and Other Severe Cancers) or HCC 21 (Lymphoma and Other Cancers) or HCC 22 (Bladder, Colorectal, and Other Cancers) is also documented for the same beneficiary, HCC 23 is dropped from the score.

ICD-10-CM codes that map to HCC 23

234 codes map to this category in the PY2027 initial mapping, concentrated in the C50 (57), C69 (27), C43 (24), D03 (23), C76 (11), Q85 (11) code families. Descriptions are the CMS mapping descriptions for the FY2026 code set; a code that is deleted or split in the October code update stays valid for dates of service before the change.

ICD-10-CM codes mapped to HCC 23 in the CMS PY2027 initial mapping
ICD-10-CMDescription
C430Malignant melanoma of lip
C4310Malignant melanoma of unspecified eyelid, including canthus
C43111Malignant melanoma of right upper eyelid, including canthus
C43112Malignant melanoma of right lower eyelid, including canthus
C43121Malignant melanoma of left upper eyelid, including canthus
C43122Malignant melanoma of left lower eyelid, including canthus
C4320Malignant melanoma of unspecified ear and external auricular canal
C4321Malignant melanoma of right ear and external auricular canal
C4322Malignant melanoma of left ear and external auricular canal
C4330Malignant melanoma of unspecified part of face
C4331Malignant melanoma of nose
C4339Malignant melanoma of other parts of face
C434Malignant melanoma of scalp and neck
C4351Malignant melanoma of anal skin
C4352Malignant melanoma of skin of breast
C4359Malignant melanoma of other part of trunk
C4360Malignant melanoma of unspecified upper limb, including shoulder
C4361Malignant melanoma of right upper limb, including shoulder
C4362Malignant melanoma of left upper limb, including shoulder
C4370Malignant melanoma of unspecified lower limb, including hip
C4371Malignant melanoma of right lower limb, including hip
C4372Malignant melanoma of left lower limb, including hip
C438Malignant melanoma of overlapping sites of skin
C439Malignant melanoma of skin, unspecified
C474Malignant neoplasm of peripheral nerves of abdomen
C494Malignant neoplasm of connective and soft tissue of abdomen
C49A0Gastrointestinal stromal tumor, unspecified site
C49A1Gastrointestinal stromal tumor of esophagus
C49A2Gastrointestinal stromal tumor of stomach
C49A3Gastrointestinal stromal tumor of small intestine
C49A4Gastrointestinal stromal tumor of large intestine
C49A5Gastrointestinal stromal tumor of rectum
C49A9Gastrointestinal stromal tumor of other sites
C50011Malignant neoplasm of nipple and areola, right female breast
C50012Malignant neoplasm of nipple and areola, left female breast
C50019Malignant neoplasm of nipple and areola, unspecified female breast
C50021Malignant neoplasm of nipple and areola, right male breast
C50022Malignant neoplasm of nipple and areola, left male breast
C50029Malignant neoplasm of nipple and areola, unspecified male breast
C50111Malignant neoplasm of central portion of right female breast
C50112Malignant neoplasm of central portion of left female breast
C50119Malignant neoplasm of central portion of unspecified female breast
C50121Malignant neoplasm of central portion of right male breast
C50122Malignant neoplasm of central portion of left male breast
C50129Malignant neoplasm of central portion of unspecified male breast
C50211Malignant neoplasm of upper-inner quadrant of right female breast
C50212Malignant neoplasm of upper-inner quadrant of left female breast
C50219Malignant neoplasm of upper-inner quadrant of unspecified female breast
C50221Malignant neoplasm of upper-inner quadrant of right male breast
C50222Malignant neoplasm of upper-inner quadrant of left male breast
C50229Malignant neoplasm of upper-inner quadrant of unspecified male breast
C50311Malignant neoplasm of lower-inner quadrant of right female breast
C50312Malignant neoplasm of lower-inner quadrant of left female breast
C50319Malignant neoplasm of lower-inner quadrant of unspecified female breast
C50321Malignant neoplasm of lower-inner quadrant of right male breast
C50322Malignant neoplasm of lower-inner quadrant of left male breast
C50329Malignant neoplasm of lower-inner quadrant of unspecified male breast
C50411Malignant neoplasm of upper-outer quadrant of right female breast
C50412Malignant neoplasm of upper-outer quadrant of left female breast
C50419Malignant neoplasm of upper-outer quadrant of unspecified female breast
C50421Malignant neoplasm of upper-outer quadrant of right male breast
C50422Malignant neoplasm of upper-outer quadrant of left male breast
C50429Malignant neoplasm of upper-outer quadrant of unspecified male breast
C50511Malignant neoplasm of lower-outer quadrant of right female breast
C50512Malignant neoplasm of lower-outer quadrant of left female breast
C50519Malignant neoplasm of lower-outer quadrant of unspecified female breast
C50521Malignant neoplasm of lower-outer quadrant of right male breast
C50522Malignant neoplasm of lower-outer quadrant of left male breast
C50529Malignant neoplasm of lower-outer quadrant of unspecified male breast
C50611Malignant neoplasm of axillary tail of right female breast
C50612Malignant neoplasm of axillary tail of left female breast
C50619Malignant neoplasm of axillary tail of unspecified female breast
C50621Malignant neoplasm of axillary tail of right male breast
C50622Malignant neoplasm of axillary tail of left male breast
C50629Malignant neoplasm of axillary tail of unspecified male breast
C50811Malignant neoplasm of overlapping sites of right female breast
C50812Malignant neoplasm of overlapping sites of left female breast
C50819Malignant neoplasm of overlapping sites of unspecified female breast
C50821Malignant neoplasm of overlapping sites of right male breast
C50822Malignant neoplasm of overlapping sites of left male breast
C50829Malignant neoplasm of overlapping sites of unspecified male breast
C50911Malignant neoplasm of unspecified site of right female breast
C50912Malignant neoplasm of unspecified site of left female breast
C50919Malignant neoplasm of unspecified site of unspecified female breast
C50921Malignant neoplasm of unspecified site of right male breast
C50922Malignant neoplasm of unspecified site of left male breast
C50929Malignant neoplasm of unspecified site of unspecified male breast
C50A0Malignant inflammatory neoplasm of unspecified breast
C50A1Malignant inflammatory neoplasm of right breast
C50A2Malignant inflammatory neoplasm of left breast
C540Malignant neoplasm of isthmus uteri
C541Malignant neoplasm of endometrium
C542Malignant neoplasm of myometrium
C543Malignant neoplasm of fundus uteri
C548Malignant neoplasm of overlapping sites of corpus uteri
C549Malignant neoplasm of corpus uteri, unspecified
C55Malignant neoplasm of uterus, part unspecified
C600Malignant neoplasm of prepuce
C601Malignant neoplasm of glans penis
C602Malignant neoplasm of body of penis
C608Malignant neoplasm of overlapping sites of penis
C609Malignant neoplasm of penis, unspecified
C61Malignant neoplasm of prostate
C6200Malignant neoplasm of unspecified undescended testis
C6201Malignant neoplasm of undescended right testis
C6202Malignant neoplasm of undescended left testis
C6210Malignant neoplasm of unspecified descended testis
C6211Malignant neoplasm of descended right testis
C6212Malignant neoplasm of descended left testis
C6290Malignant neoplasm of unspecified testis, unspecified whether descended or undescended
C6291Malignant neoplasm of right testis, unspecified whether descended or undescended
C6292Malignant neoplasm of left testis, unspecified whether descended or undescended
C6300Malignant neoplasm of unspecified epididymis
C6301Malignant neoplasm of right epididymis
C6302Malignant neoplasm of left epididymis
C6310Malignant neoplasm of unspecified spermatic cord
C6311Malignant neoplasm of right spermatic cord
C6312Malignant neoplasm of left spermatic cord
C632Malignant neoplasm of scrotum
C637Malignant neoplasm of other specified male genital organs
C638Malignant neoplasm of overlapping sites of male genital organs
C639Malignant neoplasm of male genital organ, unspecified
C6900Malignant neoplasm of unspecified conjunctiva
C6901Malignant neoplasm of right conjunctiva
C6902Malignant neoplasm of left conjunctiva
C6910Malignant neoplasm of unspecified cornea
C6911Malignant neoplasm of right cornea
C6912Malignant neoplasm of left cornea
C6920Malignant neoplasm of unspecified retina
C6921Malignant neoplasm of right retina
C6922Malignant neoplasm of left retina
C6930Malignant neoplasm of unspecified choroid
C6931Malignant neoplasm of right choroid
C6932Malignant neoplasm of left choroid
C6940Malignant neoplasm of unspecified ciliary body
C6941Malignant neoplasm of right ciliary body
C6942Malignant neoplasm of left ciliary body
C6950Malignant neoplasm of unspecified lacrimal gland and duct
C6951Malignant neoplasm of right lacrimal gland and duct
C6952Malignant neoplasm of left lacrimal gland and duct
C6960Malignant neoplasm of unspecified orbit
C6961Malignant neoplasm of right orbit
C6962Malignant neoplasm of left orbit
C6980Malignant neoplasm of overlapping sites of unspecified eye and adnexa
C6981Malignant neoplasm of overlapping sites of right eye and adnexa
C6982Malignant neoplasm of overlapping sites of left eye and adnexa
C6990Malignant neoplasm of unspecified site of unspecified eye
C6991Malignant neoplasm of unspecified site of right eye
C6992Malignant neoplasm of unspecified site of left eye
C73Malignant neoplasm of thyroid gland
C750Malignant neoplasm of parathyroid gland
C754Malignant neoplasm of carotid body
C755Malignant neoplasm of aortic body and other paraganglia
C758Malignant neoplasm with pluriglandular involvement, unspecified
C759Malignant neoplasm of endocrine gland, unspecified
C760Malignant neoplasm of head, face and neck
C761Malignant neoplasm of thorax
C762Malignant neoplasm of abdomen
C763Malignant neoplasm of pelvis
C7640Malignant neoplasm of unspecified upper limb
C7641Malignant neoplasm of right upper limb
C7642Malignant neoplasm of left upper limb
C7650Malignant neoplasm of unspecified lower limb
C7651Malignant neoplasm of right lower limb
C7652Malignant neoplasm of left lower limb
C768Malignant neoplasm of other specified ill-defined sites
C801Malignant (primary) neoplasm, unspecified
C802Malignant neoplasm associated with transplanted organ
D030Melanoma in situ of lip
D0310Melanoma in situ of unspecified eyelid, including canthus
D03111Melanoma in situ of right upper eyelid, including canthus
D03112Melanoma in situ of right lower eyelid, including canthus
D03121Melanoma in situ of left upper eyelid, including canthus
D03122Melanoma in situ of left lower eyelid, including canthus
D0320Melanoma in situ of unspecified ear and external auricular canal
D0321Melanoma in situ of right ear and external auricular canal
D0322Melanoma in situ of left ear and external auricular canal
D0330Melanoma in situ of unspecified part of face
D0339Melanoma in situ of other parts of face
D034Melanoma in situ of scalp and neck
D0351Melanoma in situ of anal skin
D0352Melanoma in situ of breast (skin) (soft tissue)
D0359Melanoma in situ of other part of trunk
D0360Melanoma in situ of unspecified upper limb, including shoulder
D0361Melanoma in situ of right upper limb, including shoulder
D0362Melanoma in situ of left upper limb, including shoulder
D0370Melanoma in situ of unspecified lower limb, including hip
D0371Melanoma in situ of right lower limb, including hip
D0372Melanoma in situ of left lower limb, including hip
D038Melanoma in situ of other sites
D039Melanoma in situ, unspecified
D1802Hemangioma of intracranial structures
D320Benign neoplasm of cerebral meninges
D321Benign neoplasm of spinal meninges
D329Benign neoplasm of meninges, unspecified
D330Benign neoplasm of brain, supratentorial
D331Benign neoplasm of brain, infratentorial
D332Benign neoplasm of brain, unspecified
D333Benign neoplasm of cranial nerves
D334Benign neoplasm of spinal cord
D337Benign neoplasm of other specified parts of central nervous system
D339Benign neoplasm of central nervous system, unspecified
D352Benign neoplasm of pituitary gland
D353Benign neoplasm of craniopharyngeal duct
D354Benign neoplasm of pineal gland
D420Neoplasm of uncertain behavior of cerebral meninges
D421Neoplasm of uncertain behavior of spinal meninges
D429Neoplasm of uncertain behavior of meninges, unspecified
D430Neoplasm of uncertain behavior of brain, supratentorial
D431Neoplasm of uncertain behavior of brain, infratentorial
D432Neoplasm of uncertain behavior of brain, unspecified
D433Neoplasm of uncertain behavior of cranial nerves
D434Neoplasm of uncertain behavior of spinal cord
D438Neoplasm of uncertain behavior of other specified parts of central nervous system
D439Neoplasm of uncertain behavior of central nervous system, unspecified
D443Neoplasm of uncertain behavior of pituitary gland
D444Neoplasm of uncertain behavior of craniopharyngeal duct
D445Neoplasm of uncertain behavior of pineal gland
D446Neoplasm of uncertain behavior of carotid body
D447Neoplasm of uncertain behavior of aortic body and other paraganglia
D45Polycythemia vera
D473Essential (hemorrhagic) thrombocythemia
D496Neoplasm of unspecified behavior of brain
Q8500Neurofibromatosis, unspecified
Q8501Neurofibromatosis, type 1
Q8502Neurofibromatosis, type 2
Q8503Schwannomatosis
Q8509Other neurofibromatosis
Q851Tuberous sclerosis
Q8581PTEN hamartoma tumor syndrome
Q8582Other Cowden syndrome
Q8583Von Hippel-Lindau syndrome
Q8589Other phakomatoses, not elsewhere classified
Q859Phakomatosis, unspecified

Where these codes sat in the V22 model

The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.

V22 categories that the HCC 23 codes mapped to
V22 HCCCodes
12223
109
482

Capturing and defending the category

A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.

Frequently asked questions

Which ICD-10 codes map to HCC 23?

234 ICD-10-CM codes map to HCC 23 in the CMS PY2027 initial mapping, for example C430 Malignant melanoma of lip; C4310 Malignant melanoma of unspecified eyelid, including canthus; C43111 Malignant melanoma of right upper eyelid, including canthus; C43112 Malignant melanoma of right lower eyelid, including canthus. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.

How much does HCC 23 add to a risk score?

The V28 relative factor for HCC 23 is 0.186 for a community, non-dual, aged beneficiary, 0.196 for full-benefit dual aged, 0.233 for non-dual disabled and 0.197 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.

Does HCC 23 count together with related categories?

No. Within a hierarchy only the most severe category is paid. HCC 23 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) or HCC 20 (Lung and Other Severe Cancers) or HCC 21 (Lymphoma and Other Cancers) or HCC 22 (Bladder, Colorectal, and Other Cancers) is also present.

What has to be documented for HCC 23 to be valid?

The diagnosis must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.